A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion

A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion

Brief description of study

The purpose of this study is to compare edoxaban with warfarin to see if it is safe and effective in preventing thromboembolism (formation of a clot [thrombus] in a blood vessel that breaks loose and is carried by the blood stream to block another vessel) and strokes which results when a brain blood vessel becomes blocked by a clot and in patients with AF who have undergone electrical cardioversion.

Detailed description of study

The purpose of this study is to compare edoxaban with warfarin to see if it is safe and effective in preventing thromboembolism (formation of a clot [thrombus] in a blood vessel that breaks loose and is carried by the blood stream to block another vessel) and strokes which results when a brain blood vessel becomes blocked by a clot and in patients with Atrial fibrillation who have undergone electrical cardioversion.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Atrial Fibrillation,electrical cardioversion,ablation,atrial fibrillation,ablation,electrical cardioversion,electrical cardioversion,ablation,electrical cardioversion,ablation
  • Age: Between 1 Years - 99 Years
  • Gender: All


Updated on 07 Sep 2022. Study ID: 820126

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center